Autonomous, living microrobots that seek and destroy cancer are not as futuristic as one might imagine, thanks to a fusion of robotics and synthetic biology.

Researchers could one day use the method to deliver antibiotics to topical wounds infected by hard-to-treat masses of bacteria.

DNA-responsive polymer gels used for releasing drugs, encapsulating cells, and much more now have greater adaptability thanks to the Cas12a nuclease.

The US Food and Drug Administration halts a study by Solid Biosciences after a patient experiences severe side effects following treatment.

A device implanted into mice can modulate brain circuit activity over long periods of time.

A microneedle delivers liquid medicines through tiny, fang-like points.

An injectable biomaterial calls cancer drugs to tumor sites in mice.

Lonza will employ more than 200 full-time staff to work at the Texas-based facility, the company says.

The artificially motorized cells may one day help fight cancers in the female reproductive tract.